Guidelines for approval of anti-obesity drugs affecting atherosclerosis and/or lipids. The international union of pharmacology (IUPHAR).
Anderson
J W
JW
Metabolic Research Group, Veterans Affairs Medical Center and University of Kentucky, Lexington, USA.
D019440:Anti-Obesity Agents / Q000627:therapeutic use*; D003324:Coronary Artery Disease / Q000097:blood / Q000188:drug therapy*; D017277:Drug Approval; D015507:Drugs, Investigational / Q000627:therapeutic use; D006801:Humans; D008055:Lipids / Q000097:blood*; D009765:Obesity / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D014481:United States; D014486:United States Food and Drug Administration
D019440:Anti-Obesity Agents; D015507:Drugs, Investigational; D008055:Lipids